Phentermine Hydrochloride Tablet
NDC Package 17224-902-45

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Phentermine Hydrochloride tablets is phentermine hydrochloride, USP 37.5 mg is indicated as short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg/m 2, or greater than or equal to 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). This formulation utilizes a tablet delivery system. Marketed by Calvin Scott & Co., Inc., this product is identified by NDC 17224-902 and is authorized under FDA application ANDA040876.

Identification & Billing

NDC Package Code
17224-902-45
Package Description
45 TABLET in 1 BOTTLE, PLASTIC
Product Code
17224-902
11-Digit Billing Format
17224090245
RxNorm Crosswalk
  • RxCUI: 803353 - phentermine HCl 37.5 MG Oral Tablet
  • RxCUI: 803353 - phentermine hydrochloride 37.5 MG Oral Tablet
  • RxCUI: 803353 - phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet

Clinical Specifications

Proprietary Name
Phentermine Hydrochloride
Non-Proprietary Name
Phentermine Hydrochloride
Substance Name
Phentermine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PHENTERMINE HYDROCHLORIDE 37.5 mg/1
Pharmacologic Class
Usage Information
Phentermine hydrochloride, USP 37.5 mg is indicated as short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg/m 2, or greater than or equal to 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). Below is a chart of Body Mass Index (BMI) based on various heights and weights.BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters.The limited usefulness of agents of this class, including Phentermine hydrochloride, [see CLINICAL PHARMACOLOGY ( 12.1, 12.2) ] should be measured against possible risk factors inherent in their use such as those described below.
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
Calvin Scott & Co., Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA040876
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-01-1978
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (17224-902). Click a package code to view its specific billing and regulatory data.

17224-902-07
7 TABLET in 1 BOTTLE, PLASTIC
17224-902-14
14 TABLET in 1 BOTTLE, PLASTIC
17224-902-21
21 TABLET in 1 BOTTLE, PLASTIC
17224-902-28
28 TABLET in 1 BOTTLE, PLASTIC
17224-902-30
30 TABLET in 1 BOTTLE, PLASTIC
17224-902-32
32 TABLET in 1 BOTTLE, PLASTIC
17224-902-56
56 TABLET in 1 BOTTLE, PLASTIC
17224-902-60
60 TABLET in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17224-902-45 identifies a specific commercial package of 45 tablet in 1 bottle, plastic of Phentermine Hydrochloride, a human prescription drug labeled by Calvin Scott & Co., Inc.. This tablet is formulated for oral use and contains phentermine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Calvin Scott & Co., Inc. on January 01, 1978. The current certification is valid through December 31, 2026.

How is this Calvin Scott & Co., Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17224090245. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17224-902-45
11-Digit CMS (5-4-2)
17224-0902-45

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.